OPUNTIA FICUS-INDICA EXTRACT

Description: OPUNTIA FICUS-INDICA EXTRACT — antioxidant, soothing (Prickly Pear).

All Functions: antioxidant, soothing (Prickly Pear)

Quick Facts:

• Category: active

Proven Benefits At A Glance:

• Opuntia ficus-indica extract comes from a cactus species traditionally used in skincare
• Research suggests it may help restore skin barrier function and reduce inflammation
• In psoriasis studies, it performed comparably to prescription treatments with good tolerability
• Lab studies show it activates antioxidant defenses in skin cells
• It may accelerate skin cell migration and repair in wound healing contexts

Safety tier is a starting heuristic from regulatory status and comedogenic rating, not a dermatological verdict — see our Terms for the full disclaimer. Research confidence reflects how many real cited studies back this ingredient, not the strength of their findings.

🧪 OPUNTIA FICUS-INDICA EXTRACT

OPUNTIA FICUS-INDICA EXTRACT

CAS Number: 90082-21-6

Also Known As: —

Category: active

EC Number: 290-109-1

Korean Name: 보검선인장추출물

Opuntia Ficus-Indica Extract is the extract of the whole plant of the Fig, Opuntia ficus-indica, Cactaceae

OPUNTIA FICUS-INDICA EXTRACT is an active ingredient used in skincare formulations.

🌍 Regulatory Status

📊 Comedogenicity

📚 Research & Evidence

🔬 The Science

Opuntia ficus-indica extract (often abbreviated OFI or OFIE) is derived from a cactus and has been studied for its effects on inflammatory skin conditions, particularly psoriasis. Here’s what the research shows:

#1: Barrier restoration and psoriasis: When formulated into a topical cream alongside xyloglucan and pea proteins (XPO), the extract significantly reduced *S. aureus* adhesion and skin invasion in lab-grown skin cells, and restored the structural integrity of the outermost skin layer (Int J Mol Sci, 2023). In mice with psoriasis-like skin inflammation, XPO reduced redness, inflammatory markers, and abnormal skin thickening—performing better than the steroid dexamethasone in that model (Int J Mol Sci, 2023).

In a human clinical trial of 42 patients with mild-to-moderate plaque psoriasis over 28 days, the XPO formulation achieved similar improvements to a prescription combination (calcipotriol and betamethasone) in reducing disease severity, redness, itching, and scaling, with an “excellent tolerability profile” reported (J Clin Aesthet Dermatol, 2024). #2: Antioxidant mechanism: The extract activates a cellular defense pathway called AHR-NRF2-NQO1 signaling (J Med Food, 2015). In plain terms: when keratinocytes (the main cell type in your outer skin layer) were exposed to inflammatory triggers or oxidative stress, OFIE extract activated protective proteins that reduced damaging free radicals. Importantly, this effect was blocked when the key protein NRF2 was removed from cells, confirming this is the operative mechanism (J Med Food, 2015).

The same signaling also upregulated two important barrier proteins—filaggrin and loricrin—which are often depleted in barrier-disrupted skin disorders (J Med Food, 2015). #3: Wound repair acceleration: In lab studies using chitosan-based wound dressings loaded with Opuntia extract, skin cells (keratinocytes) migrated approximately 3-fold faster across a scratch wound when the extract was present compared to unloaded films, suggesting accelerated repair activity (Carbohydr Polym, 2021). Limitation: The human psoriasis trial involved only 42 patients over 28 days, so larger and longer studies would strengthen confidence in these findings. Most supportive data comes from the extract combined with other ingredients (xyloglucan and pea protein) rather than opuntia alone.

💧 Skin Type Compatibility

⚠️ Don’t Combine With

🧴 Products Containing OPUNTIA FICUS-INDICA EXTRACT

• Laab MEN Multi-Booster Ultralekki krem nawilżająco-kojący
• TRESemmé Curl Conditioning Mousse
• Drunk Elephant T.L.C. Framboos Glycolic Night Serum
• Bioaqua 7x Ceramide Skin Barrier Repair Moisturize Cream

📄 Related Research

Matched by search — not necessarily verified support for every statement above.

• Filippone A et al. (2023). Evaluation of the Efficacy of Xyloglucan, Pea Protein and Opuntia ficus-indica Extract in a Preclinical Model of Psoriasis. Int J Mol Sci.
• Veraldi S et al. (2024). A Prospective, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of a Cream Containing Xyloglucan, Pea Protein, and Opuntia ficus-indica Extract Versus Calcipotriol/Betamethasone in Adult Patients with Mild-to-moderate Psoriasis. J Clin Aesthet Dermatol.
• Catanzano O et al. (2021). PEG-crosslinked-chitosan hydrogel films for in situ delivery of Opuntia ficus-indica extract. Carbohydr Polym.
• Nakahara T et al. (2015). Antioxidant Opuntia ficus-indica Extract Activates AHR-NRF2 Signaling and Upregulates Filaggrin and Loricrin Expression in Human Keratinocytes. J Med Food.